PDE5A and neurodegenerative disease: Phosphodiesterases, especially those of Pde4 and Pde5 families, are well-known regulators of microglia activation and serve as targets for the development of small molecules to manage neuroinflammation and treat neurodegenerative diseases, alongside other neuroinflammation-related pathologies (Pearse and Hughes 2016; Sanders 2020).